Somnomed Limited (AU:SOM) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
SomnoMed Limited has announced the appointment of Benjamin Gisz as a new director on 8 October 2024, who has a notable interest in 67,716,079 ordinary shares of the company through his relevant interest in TDM Growth Partners Pty Ltd. The declaration made under ASX listing rules marks a significant update to the company’s directorial interests.
For further insights into AU:SOM stock, check out TipRanks’ Stock Analysis page.
